{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:17:04Z","timestamp":1790381824910,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      From January to May 2019, large measles outbreaks affected Nigeria. Borno state was the most affected, recording 15,237 suspected cases with the state capital of Maiduguri having 1125 cases investigated and line-listed by March 2019. In Borno state, 22 of the 27 Local Government Areas (LGAs or Districts), including 37 internally displaced persons (IDPs) camps were affected\n                      <jats:bold>.<\/jats:bold>\n                      In response to the situation, an outbreak response immunization (ORI) campaign was conducted in the 13 most affected LGAs. In addition to conventional vaccination teams, special teams were deployed in security compromised areas, areas with migrants, and for nomadic and IDPs. Here we describe the outbreak and the ORI campaign. We also assess the measles-containing vaccine (MCV) coverage and vaccine effectiveness (VE) in order to quantify the population-level impact.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed the ORI activities, and conducted an analysis of the surveillance and the outbreak investigation reports. We assessed VE of MCV by applying the screening-method. Sensitivity analyses were also conducted to assess the effect of final classification of cases on the VE of MCV. The MCV coverage was assessed by a post-campaign coverage survey after completion of the ORI through a quantitative survey in the 12 LGAs that were accessible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the total 15,237 reported measles cases, 2002 cases were line-listed and investigated, and 737 were confirmed for measles by week 9 of 2019. Of the investigated cases 67.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091348) were between 9 and 59\u2009months of age. Among the 737 confirmed cases, only 9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200964) stated being vaccinated with at least 1 dose of MCV. The overall VE for MCV was 98.4% (95%CI: 97.8\u201398.8). No significant differences were observed in the VE estimates of lab-confirmed and epi-linked cases when compared to the original estimates. The aggregated weighted vaccination coverage was 85.7% (95% CI: 79.6\u201390.1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The experience in Borno demonstrates that adequate VE can be obtained in conflict-affected areas. In complex emergencies affected by measles outbreaks, health authorities may consider integration with other health strategies and the engagement of security personnel as part of the ORI activities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-021-10436-1","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T07:02:43Z","timestamp":1614841363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019"],"prefix":"10.1186","volume":"21","author":[{"given":"Anne Eudes","family":"Jean Baptiste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Luce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balcha","family":"Masresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Klinkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Veldhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Dieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obianuju Caroline","family":"Ikeonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Meleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audu","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Braka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hahn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A. M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"10436_CR1","first-page":"649","volume":"93","author":"World Health Organization (WHO)","year":"2018","unstructured":"World Health Organization (WHO). Progress towards regional measles elimination \u2013 worldwide, 2000\u20132017. Weekly Epidemiol rec 48. 2018;93:649\u201360 2018.","journal-title":"Weekly Epidemiol rec 48"},{"key":"10436_CR2","first-page":"581","volume":"94","author":"World Health Organization (WHO)","year":"2019","unstructured":"World Health Organization (WHO). Progress towards regional measles elimination \u2013 worldwide, 2000\u20132018. Weekly Epidemiol rec 49. 2019;94:581\u2013600 Available from: http:\/\/www.","journal-title":"Weekly Epidemiol rec 49"},{"key":"10436_CR3","doi-asserted-by":"crossref","unstructured":"Ophori EA, Tula MY, Azih AV, Okojie R, Ikpo PE. Current Trends of Immunization in Nigeria: Prospect and Challenges. Trop Med Health. 2014.","DOI":"10.2149\/tmh.2013-13"},{"key":"10436_CR4","volume-title":"The Federal Republic of Nigeria Nigeria Demographic and Health Survey 2018 National population commission Abuja, Nigeria","author":"STATISTICS NBO, SOC","year":"2019","unstructured":"STATISTICS NBO, SOC. The Federal Republic of Nigeria Nigeria Demographic and Health Survey 2018 National population commission Abuja, Nigeria 2019. Available from: www.DHSprogram.com."},{"key":"10436_CR5","unstructured":"WHO. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2017."},{"issue":"1","key":"10436_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1752-1505-5-21","volume":"5","author":"RF Grais","year":"2011","unstructured":"Grais RF, Strebel P, Mala P, Watson J, Nandy R, Gayer M. Measles vaccination in humanitarian emergencies: A review of recent practice. Confl Heal. 2011;5(1):21 Available from: http:\/\/www.conflictandhealth.com\/content\/5\/1\/21. BioMed Central Ltd.","journal-title":"Confl Heal"},{"issue":"5","key":"10436_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4269\/ajtmh.2003.68.545","volume":"68","author":"L Talley","year":"2003","unstructured":"Talley L, Salama P. Short report: assessing field vaccine efficacy for measles in famine-affected rural Ethiopia. Am J Trop Med Hyg. 2003;68(5):545\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"10436_CR8","first-page":"45","volume":"WHO\/IVB\/09","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Response to measles outbreaks in measles mortality reduction settings. World Health Organ. 2009;WHO\/IVB\/09:45 Available from: http:\/\/whqlibdoc.who.int\/hq\/2009\/WHO_IVB_09.03_eng.pdf.","journal-title":"World Health Organ"},{"key":"10436_CR9","unstructured":"Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985."},{"key":"10436_CR10","doi-asserted-by":"crossref","unstructured":"Uzicanin A, Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: A review of published literature. J Infect Dis. 2011;204(SUPPL. 1).","DOI":"10.1093\/infdis\/jir102"},{"key":"10436_CR11","volume-title":"SOCIAL STATISTICS IN NIGERIA Federal Republic of Nigeria","author":"STATISTICS NBO, SOC","year":"2009","unstructured":"STATISTICS NBO, SOC. SOCIAL STATISTICS IN NIGERIA Federal Republic of Nigeria. 2009."},{"key":"10436_CR12","volume-title":"Humanitarian Snapshot : New Displacement in Borno State since 1 Nov 2018","author":"OCHA","year":"2019","unstructured":"OCHA. Humanitarian Snapshot : New Displacement in Borno State since 1 Nov 2018. 2019."},{"key":"10436_CR13","doi-asserted-by":"crossref","unstructured":"Masresha BG, Braka F, Onwu NU, et al. Progress Towards Measles Elimination in Nigeria: 2012\u20132016. J Immunol Sci Res Artic Immun African Reg Prog Towar Measles Elimin. 2018;(2018):2012\u20136 Available from: http:\/\/www.immunologyresearchjournal.com\/articles\/progress-towards-measles-elimination-in-nigeria-2012%2D%2D2016.pdf.","DOI":"10.29245\/2578-3009\/2018\/si.1120"},{"key":"10436_CR14","unstructured":"World Health Organization. WHO | Measles and Rubella Surveillance Data. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/active\/measles_monthlydata\/en\/. Cited 2020 Sep 21"},{"key":"10436_CR15","unstructured":"WHO. Measles - Vaccine Preventable Diseases. WHO\/Vaccine and Biologicals. 2018. p. 1\u201330."},{"key":"10436_CR16","unstructured":"WHO Regional Office for Africa. African Regional Guideline for Measles and Rubella Surveillance. 2015;Revised Ve(April 2015):1\u201382 Available from: http:\/\/www.afro.who.int\/sites\/default\/files\/2017-06\/who-african-regional-measles-and-rubella-surveillance-guidelines_updated-draft-version-april-2015_1.pdf."},{"key":"10436_CR17","doi-asserted-by":"crossref","unstructured":"Nkwogu L, Shuaib F, Braka F, Mkanda P, Banda R, Korir C, et al. Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state, Nigeria. BMC Public Health. 2018;18(Suppl 4).","DOI":"10.1186\/s12889-018-6188-9"},{"key":"10436_CR18","unstructured":"Biostat Global Consulting. VCQI Resources. Available from: http:\/\/www.biostatglobal.com\/VCQI_resources.html. Cited 2020 Jan 4"},{"key":"10436_CR19","doi-asserted-by":"crossref","unstructured":"Orenstein WA, Cairns L, Hinman A, Nkowane B, Oliv\u00e9 JM, Reingold AL. Measles and Rubella Global Strategic Plan 2012\u20132020 midterm review report: Background and summary. Vaccine. 2018.","DOI":"10.1016\/j.vaccine.2017.10.065"},{"key":"10436_CR20","volume-title":"Post measles campaign coverage survey Main survey report","author":"NPHCDA N","year":"2018","unstructured":"NPHCDA N. Post measles campaign coverage survey Main survey report. 2018."},{"issue":"1","key":"10436_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2471\/BLT.18.211565","volume":"97","author":"S Bawa","year":"2019","unstructured":"Bawa S, McNab C, Nkwogu L, et al. Using the polio programme to deliver primary health care in Nigeria: implementation research. Bull World Health Organ. 2019;97(1):24\u201332.","journal-title":"Bull World Health Organ"},{"key":"10436_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1017\/S0950268802007458","volume":"129","author":"S Yamaguchi","year":"2002","unstructured":"Yamaguchi S, Dunga A, Broadhead RL, Brabin BJ. Epidemiology of measles in Blantyre, Malawi : analyses of passive surveillance data from 1996 to 1998. Epidemiol Infect Camb Univ Press. 2002;129:361\u20139.","journal-title":"Epidemiol Infect Camb Univ Press"},{"key":"10436_CR23","volume-title":"Meeting Report Meeting to share lessons learnt from the roll-out of the 2015 WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operational research agenda around vaccination coverage surveys","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO). Meeting Report Meeting to share lessons learnt from the roll-out of the 2015 WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operational research agenda around vaccination coverage surveys 2017. Available from: http:\/\/bit.ly\/WHO-vax-survey-mtg"},{"key":"10436_CR24","unstructured":"Torvaldsen S, Mcintyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. 2002;26:451\u20137."},{"issue":"52","key":"10436_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1098\/rsif.2010.0086","volume":"7","author":"M Van Boven","year":"2010","unstructured":"Van Boven M, Kretzschmar M, Wallinga J, O\u2019Neill PD, Wichmann O, Hahn\u00e9 S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7(52):1537\u201344.","journal-title":"J R Soc Interface"},{"key":"10436_CR26","first-page":"1","volume-title":"WHO\/UNICEF Joint Statement on reducing measles mortality in emergencies","author":"World Health Organization, UNICEF","year":"2004","unstructured":"World Health Organization, UNICEF. WHO\/UNICEF Joint Statement on reducing measles mortality in emergencies; 2004. p. 1\u20134. Available from: http:\/\/www.unicef.org\/publications\/index_4444.html"},{"key":"10436_CR27","first-page":"1","volume-title":"Vaccination in Humanitarian Emergencies: Literature review and case studies","author":"SAGE Working Group on vaccination in humanitarian emergencies","year":"2011","unstructured":"SAGE Working Group on vaccination in humanitarian emergencies. Vaccination in Humanitarian Emergencies: Literature review and case studies. 2011; (September):1\u201321."},{"key":"10436_CR28","doi-asserted-by":"crossref","unstructured":"Kouadio IK, Kamigaki T, Oshitani H. Measles outbreaks in displaced populations: A review of transmission, morbidity and mortality associated factors. BMC Int Health Hum Rights. 2010;10.","DOI":"10.1186\/1472-698X-10-5"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10436-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-021-10436-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10436-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T07:06:01Z","timestamp":1614841561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-10436-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10436"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-10436-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-34385\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-34385\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-34385\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The analyses for this work was built on secondary data, which does not elicit consultation of an ethics committee and consent to participate, is not required. In coverage surveys written consent is not required. However, verbal consent to participate was obtained from each participant during the interview.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}